BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32245383)

  • 21. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
    Look AT
    Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
    Deucher AM; Qi Z; Yu J; George TI; Etzell JE
    Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
    Yamamoto K; Kawamoto S; Mizutani Y; Yakushijin K; Yamashita T; Nakamachi Y; Kawano S; Hayashi Y; Matsuoka H; Minami H
    Cytogenet Genome Res; 2016; 149(3):165-170. PubMed ID: 27607436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.
    Yilmaz M; Kantarjian HM; Toruner G; Yin CC; Kanagal-Shamanna R; Cortes JE; Issa G; Short NJ; Khoury JD; Garcia-Manero G; Ravandi F; Kadia T; Konopleva M; Wierda WG; Jain N; Estrov Z; Sasaki K; Pierce S; O'Brien SM; Jabbour EJ
    Leuk Lymphoma; 2021 Jan; 62(1):224-228. PubMed ID: 32955970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP; Ohyashiki K; Toyama K; Cleary ML
    Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
    Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
    Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
    Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
    Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.
    Moorman AV
    Haematologica; 2016 Apr; 101(4):407-16. PubMed ID: 27033238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
    Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
    Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for a Patient With Tcf3-Hlf-Positive Acute Lymphoblastic Leukemia Extramedullary Relapse After Unrelated Bone Marrow Transplantation.
    Takahashi N; Mochizuki K; Kobayashi S; Ohara Y; Kudo S; Saito Y; Ikeda K; Ohto H; Kikuta A; Sano H
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e419-e422. PubMed ID: 36162014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.
    Jeha S; Pei D; Raimondi SC; Onciu M; Campana D; Cheng C; Sandlund JT; Ribeiro RC; Rubnitz JE; Howard SC; Downing JR; Evans WE; Relling MV; Pui CH
    Leukemia; 2009 Aug; 23(8):1406-9. PubMed ID: 19282835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.
    Ahmed MZ; Venkatadasari I; Dyer S; Wall K; Huxley E; Lovell R; Kishore B; Dassanayake H; Francis S; Nikolousis E; Kanellopoulos A
    Ann Hematol; 2022 Nov; 101(11):2553-2554. PubMed ID: 35907039
    [No Abstract]   [Full Text] [Related]  

  • 37. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations.
    Maloney KW; McGavran L; Odom LF; Hunger SP
    Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
    Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.